These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The correction of hyperuricemia in patients with different forms of nephrolithiasis using allopurinol and Allomaron].
    Author: Darenkov AF, Konstantinova OV, Ianenko EK.
    Journal: Urol Nefrol (Mosk); 1994; (5):35-7. PubMed ID: 7871619.
    Abstract:
    Metabolic status was assessed in 48 patients with nephrolithiasis followed-up for 4 years. Allopurinol and allomaron-treated patients were examined biochemically by 17 parameters of the blood and urine. The effects of the drugs were compared. It is concluded that in hyperuricemia up to 0.37 +/- 0.02 mmol/l allomaron is more effective (1--2 pills a day). In higher hyperuricemia allopurinol is preferable (4 pills a day). Allomaron can be also used (1--2 pills a day) under the control of urinalysis.
    [Abstract] [Full Text] [Related] [New Search]